NANOS3 anticorps (AA 21-192) (Biotin)

N° du produit ABIN7161040

Cet anticorps anti-NANOS3 est un anticorps Lapin Polyclonal détectant NANOS3 dans ELISA. Adapté pour Humain.

Aperçu rapide pour NANOS3 anticorps (AA 21-192) (Biotin) (ABIN7161040)

Antigène: NANOS3 (Nanos Homolog 3 (NANOS3))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NANOS3 est conjugé à/à la Biotin

Application: ELISA

Détail du produit anti-NANOS3 anticorps (Biotin)

Épitope: AA 21-192

Fonction: NANOS3 Antibody, Biotin conjugated

Purification: Protein G purified

Pureté: >95 %

Immunogène: Recombinant Human Nanos homolog 3 protein (21-192AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur NANOS3

Antigène: NANOS3 (Nanos Homolog 3 (NANOS3))

Autre désignation: NANOS3

Sujet:

Background: Plays a role in the maintenance of the undifferentiated state of germ cells regulating the spermatogonia cell cycle and inducing a prolonged transit in G1 phase. Affects cell proliferation probably by repressing translation of specific mRNAs. Maintains the germ cell lineage by suppressing both Bax-dependent and -independent apoptotic pathways. Essential in the early stage embryo to protect the migrating primordial germ cells (PGCs) from apoptosis.

Aliases: NANO3_HUMAN antibody, Nanos homolog 3 antibody, NANOS3 antibody, NOS-3 antibody, Nos3 antibody

UniProt: P60323

Pathways: ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling